This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Qiagen Gmbh. Active years: 2001-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2011
Title: Martin Weber: Innovator in Nucleic Acid Enrichment and Targeted Transfection
Introduction
Martin Weber is a notable inventor based in Leichlingen, Germany. He has made significant contributions to the field of molecular biology, particularly in the areas of nucleic acid enrichment and targeted transfection techniques. With a total of 4 patents to his name, Weber's work has the potential to impact gene therapy and related applications.
Latest Patents
Weber's latest patents include a method for enriching short-chain nucleic acids. This invention focuses on a method for enriching nucleic acids that are not more than 300 nucleotides in length. It also encompasses a kit designed for this purpose, along with the use of an anion exchange matrix and a method for treating diseases. Another significant patent involves the targeted transfection of cells using a biotinylated dendrimer. This invention outlines processes for the targeted introduction of nucleic acids into cells, utilizing a complex of nucleic acid and dendrimer, which is biotinylated. The process includes mixing this complex with a second complex that consists of avidin or streptavidin and a biotinylated target-specific binding molecule, followed by incubation with the target cells.
Career Highlights
Throughout his career, Martin Weber has worked with prominent companies in the biotechnology sector, including Qiagen GmbH and Qiagen Gesellschaft mit beschränkter Haftung. His experience in these organizations has contributed to his expertise in molecular biology and patent development.
Collaborations
Weber has collaborated with notable colleagues such as Christoph Erbacher and Stephan Wahle. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Martin Weber's innovative work in nucleic acid enrichment and targeted transfection showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing gene therapy techniques, which may lead to improved treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile